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Abstract
Patterning multiple cell types is a critical step for engineering functional tissues, but few methods
provide three-dimensional positioning at the cellular length scale. Here, we present a “bottom-up”
approach for fabricating multicellular tissue constructs that utilizes DNA-templated assembly of
3D cell-laden hydrogel microtissues. A flow focusing-generated emulsion of photopolymerizable
prepolymer is used to produce 100 μm monodisperse microtissues at rates of 100 Hz (105/hr).
Multiple cell types, including suspension and adherently cultured cells, can be encapsulated into
the microtissues with high viability (~97%). We then use a DNA coding scheme to self-assemble
microtissues “bottom-up” from a template that is defined using “top-down” techniques. The
microtissues are derivatized with single-stranded DNA using a biotin-streptavidin linkage to the
polymer network, and are assembled by sequence-specific hybridization onto spotted DNA
microarrays. Using orthogonal DNA codes, we achieve multiplexed patterning of multiple
microtissue types with high binding efficiency and >90% patterning specificity. Finally, we
demonstrate the ability to organize multicomponent constructs composed of epithelial and
mesenchymal microtissues while preserving each cell type in a 3D microenvironment. The
combination of high throughput microtissue generation with scalable surface-templated assembly
offers the potential to dissect mechanisms of cell-cell interaction in three dimensions in healthy
and diseased states as well as provides a framework for templated assembly of larger structures for
implantation.
Introduction
The three-dimensional microscale architecture of living tissues provides vital environmental
cues, including extracellular matrix, soluble factors and cell-cell interactions.1-2 Paracrine
and autocrine cell signaling are critical factors guiding tissue development3-4 and
maintenance,5-6 and dysregulation of these cues contributes to the pathogenesis of diseased
states such as cancer.7-9 Understanding and emulating these cell-cell interactions has been
shown to be critical in engineering functional tissues in both 2D10-13 and 3D14-16 systems.
In 3D culture, top-down approaches for organizing multiple cell types such as
dielectrophoresis,17-18 photopatterning,19-20 and microfabrication21 provide high-precision
control over cell placement, but are challenging to scale-up for the assembly of mesoscale
tissues.
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In contrast, bottom-up methods, wherein small tissue building blocks are assembled into
larger structures, have potential for creating multicellular constructs in a facile, scalable
fashion.22-26 Living tissues are comprised of repeating units on the order of hundreds of
microns; therefore, synthetic microtissues comprised of cell-laden hydrogels in this size
range27 represent appropriate fundamental building blocks of such bottom-up methods.
Synthetic microtissues of this size have been previously assembled in packed-bed
reactors22, 28 or by hydrophobic/hydrophilic interactions24, 29 but without the ability to
specify the placement of many different microtissues relative to one another. One potential
method for controlled assembly of heterostructures would be to incorporate the specificity of
biomolecular interactions with surface templating to direct assembly. This approach could
allow for scalable patterning of multiple cell types into arbritrary architectures with high
precision.
In this work, we harness the well-characterized molecular recognition capabilities of DNA
to achieve rapid templated assembly of multiple microtissue types (Fig. 1). This method is
enabled by the high-throughput production of spherical cell-laden microtissues from a
microfluidically-derived, monodispersed emulsion of a photocurable hydrogel. Cell-laden
microtissues are derivatized with single-stranded oligonucleotides and integrated with
custom DNA microarray templates. Orthogonal DNA sequences are used to specify the
assembly of multiple cell types over large (~mm) length scales with high capture efficiency.
This fusion of ‘bottom-up’ (templated assembly) and ‘top-down’ (microfluidics and robotic
spotting) approaches allows for unprecedented control over mesoscale tissue




Microfluidic device masters were fabricated on 4 inch silicon wafers using standard
photolithographic methods, with SU-8 2050 photoresist (Microchem, MA) spin coated at
1200 rpm to create 125 μm tall features. Masters were coated with trichloro perfluorooctyl
silane (Sigma-Aldrich) for 1 hr in a vacuum dessicator prior to casting polydimethylsiloxane
(PDMS, Dow Corning) devices. Cured devices with inlet holes made by a 20G dispensing
needle (McMaster-Carr) were bonded to glass slides following air plasma treatment. In order
to ensure a hydrophobic surface for droplet generation, Aquapel (PPG Industries) was
briefly injected into the device and flushed out with nitrogen.
Ligand conjugation
Acrylate-PEG-RGDS peptide was prepared as previously described.14 To conjugate
streptavidin with acrylate groups, streptavidin was dissolved in 50 mM sodium bicarbonate
(pH 8.5) at 0.8 mg/ml. Amine-reactive acrylate-PEG-SVA (3.4 kDa, Laysan) was added at a
25:1 molar ratio and allowed to react with the protein at room temperature for 2 hours.
Conjugated acrylate-PEG-streptavidin was purified from unconjugated PEG by washing in
PBS with a 30,000 MWCO spin filter (Millipore). The acrylate-PEG-streptavidin conjugate
was then reconstituted to 38 μM streptavidin in PBS, sterile filtered, and stored at −20°C.
Microtissue polymerization
Irgacure-2959 initiator (Ciba) was dissolved at 100 mg/ml in n-vinyl pyrrolidinone
accelerator (Sigma-Aldrich) to make photoinitiator working solution. The basic 2×
concentrated prepolymer solution consisted of 20% w/v poly(ethylene glycol) diacrylate
(PEG-DA, 20kDa, Laysan ) and 2 % v / v of photoinitiator working solution. Additional
prepolymer ingredients included 38 μM of acrylate-PEG-streptavidin conjugate, 1 0 μM
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acrylate-PEG-RGDS, and/or 1% v/v of fluorescent microspheres (2% solids, Invitrogen) as
markers.
The final 2× prepolymer solution was injected into the microencapsulation device in parallel
with, for cell-free microtissues, a 1:1 diluting stream of PBS. Syringe pumps were used to
control the flow rates of the aqueous phases and the oil phase, which consisted of the
perfluoro polyether, Fomblin (Y-LVAC, Solvay Solexis), with 0-2 w/v% Krytox 157 FSH
surfactant (DuPont). Prepolymer droplets were gelled on-chip by exposure to 500 mW/cm2
of 320-390 nm UV light (Omnicure S1000, Exfo) for an approximately one second
residence time under typical flow conditions. Cell-free microtissues were collected in
handling buffer (PBS with 0.1% v/v Tween-20), allowed to separate from the oil phase, and
washed on a 70 μm cell strainer to remove un-polymerized solutes.
Bead hybridization
To stain for the surface-availability of ssDNA bound on microtissues, 1 μm NeutrAvidin
biotin-binding beads (yellow-green, Invitrogen) were coated with the complementary
5′biotin-DNA (IDTDNA). The original suspension of beads (1% solids) was diluted 1:10
with BlockAid blocking solution (Invitrogen), sonicated for 5 minutes, and then incubated
with a final concentration of 4 μM 5′biotin-DNA for 1 hour at room temperature. Beads
were then washed three times in PBS by centrifugation at 2000×g. DNA-functionalized
microtissues were incubated overnight on a room-temperature shaker with coated beads
resuspended to 0.1% solids in BlockAid.
Microarray spotting
Microarray templates were printed in-house using a contactdeposition DNA spotter
(Cartesian Technologies ) with a 946MP10 pin (Arrayit). Complementary pairs of single-
stranded oligonucleotides used to functionalize microtissues and template their assembly are
listed below and consisted of a poly-A linker followed by a heterogeneous 20 nucleotide
sequence. The 20-nucleotide binding region of A and A’ are complementary, B and B’, etc.
Sequences were modified with 5′-amine groups for microarray spotting, and 5′-biotin










5′-amino oligonucleotides (IDTDNA) for templating were dissolved in 150 mM phosphate
buffer (pH 8.5) at concentrations up to 250 μM, and spotted on epoxide coated slides
(Corning) at 70% RH. Patterned slides were then incubated for 12 hours in a 75% RH
saturated NaCl chamber, blocked for 30 minutes in 50 mM ethanolamine in 0.1M Tris with
0.1% w/v SDS (pH 9), and rinsed thoroughly with deionized water.
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Microtissues containing PEG-streptavidin were incubated with 1 nmol of 5′-biotin
oligonucleotides per 10 ul of packed microtissues for one hour at room temperature or
overnight at 4°C. Un-bound oligonucleotides were removed by washing microtissues on a
70 μM cell strainer or using 100,000 MWCO spin filters. Multi-well chambers (ProPlate,
Grace Bio-Labs) were assembled over templating slides, and DNA-functionalized
microtissues were seeded in a concentrated suspension over the microarray patterns.
Microtissues quickly settled into a monolayer, which was visually confirmed under a
microscope. Unbound microtissues were washed off the template by gently rinsing the slide
with several ml of handling buffer. Capture efficiency was quantified by measuring the
average seeding density of settled microtissues in a 4× microscope field of view, divided by
the average capture density over replicate spots on a slide. Percent of maximum packing
fraction was calculated as the ratio of capture density to the theoretical density of close-
packed circles.
Cell culture
J2-3T3 fibroblasts were cultured in Dulbecco’s Modified Eagle Medium (DMEM,
Invitrogen) with 10% bovine serum (Invitrogen), 10 U/ml penicillin (Invitrogen), and 10
mg/ml streptomycin (Invitrogen). TK6 lymphoblasts (suspension culture) and A549 lung
adenocarcinoma cells were cultured in RPMI 1640 with L-glutamine (Invitrogen) and 10%
fetal bovine serum (Invitrogen), 10 U/ml penicillin, and 10 mg/ml streptomycin. All cells
were cultured in a 5% CO2 humidified incubator at 37°C.
Cell encapsulation
Prior to encapsulation, adherent cells (J2-3T3 and A549) were detached with 0.25% trypsin-
EDTA (Invitrogen). Cell pellets were resuspended at cell densities between 10×106 cells/ml
and 30×106 cells/ml in an isopycnic injection medium consisting of 20% v/v OptiPrep
(Sigma-Aldrich) in serum-free DMEM. Isopycnic cell suspensions were injected into
microencapsulation devices in place of the diluting stream of PBS, along with 2×
prepolymer solution. Gelled microtissues were collected and handled in culture media. To
assess cell viability after 3 hours, microtissues stained with calcein AM (1:200, 1 mg/ml in
DMSO, Invitrogen) and ethidium homodimer (1:400, 1 mg/ml in DMSO, Invitrogen) for 15
minutes at 37°C. Alternatively, microtissues for DNA-templated assembly were marked
with CellTracker Green CMFDA (1:200, 5 mg/ml in DMSO, Invitrogen) or CellTracker
Blue CMAC (1:200, 5 mg/ml in DMSO, Invitrogen) for 1 hour at 37°C.
Imaging and visualization
Images were acquired with a Nikon Ellipse TE200 inverted fluorescence microscope, a
CoolSnap-HQ Digital CCD Camera, and MetaMorph Image Analysis Software. NIH
software ImageJ was used to uniformly adjust brightness/contrast, and pseudocolor, merge,
and quantify images. Confocal images were acquired with an Olympus FV1000 multiphoton
microscope and Olympus Fluoview software. NIS-Elements software was used to
pseudocolor and reconstruct maximum intensity, slice, and volume views.
Results and Discussion
High-throughput microtissue fabrication
One factor restricting the application of bottom-up assembly to tissue engineering has been
the low throughput of typical microtissue fabrication approaches to date, many of which are
batch processes.22, 27, 30 We first sought to design a microfluidic chip to rapidly produce
uniform microtissues. Droplets generated by flow focusing of aqueous/oil phases are
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monodisperse and amenable to photopolymerization.31 Thus, we fabricated a device to shear
photopolymerizable poly(ethylene glycol) diacrylate (PEG) prepolymer containing cells into
droplets in oil for downstream gelation by UV-light (Fig. 2a). Concentrated pre-polymer
was injected into the microencapsulation device as a separate stream from the cell
suspension (PBS for cell-free microtissues), where the two aqueous streams were designed
to meet before reaching a flow-focusing junction (Fig. 2b, Movie S1). With a 60 μm nozzle,
shear forces were sufficient to disperse the aqueous combination into droplets that passed
through a corrugated serpentine channel32 to thoroughly mix the cell-prepolymer solution
(Fig. 2c). The droplets were then polymerized by UV irradiation for 1 second during
transport to the outlet. Resulting microtissues were uniformly spherical and monodisperse
(Fig. 2d). We observed that by adjusting aqueous vs. oil phase flow rates (Fig. 2e) and oil-
phase surfactant concentrations (Fig. 2f), we could finely control droplet diameter, and
hence microtissue size, between 30-120 μm.
At a typical prepolymer flow rate of 200 ul/hr, our device was capable of achieving a
production throughput of 6000 microtissues/min (~105/hr), two orders of magnitude faster
than other continuous systems such as stop-flow lithography33 (~103 particles/hr) or batch
fabrication processes.27 Microtissue fabrication by microfluidic droplet photopolymerization
provides precise control over microtissue shape and size, whereas photolithographic27 and
molding22, 24 techniques do not produce spherical gels and can suffer from resolution limits.
Planar microtissue surfaces tend to adhere non-specifically to hydrophilic surfaces due to the
high water content (>90%34) of the hydrogel material, whereas the low contact area of
spherical microtissues reduces capillary adhesion during both handling and assembly.
Droplet-based gels have previously been made using agarose35 or alginate;36 here, we chose
a PEG hydrogel material for its biocompatibility and biochemical versatility. PEG-diacrylate
hydrogels have high water content, are non-immunogenic and resistant to protein adsorption,
and can be easily customized with degradable linkages, adhesive ligands, and other
biologically or chemically active factors.37
Microtissue functionalization with surface-encoding DNA
Having established a method to uniformly produce microtissues, we next sought to modify
our microtissues with streptavidin for binding biotinylated DNA. To accomplish this,
streptavidin was incubated with amine-reactive acrylate-PEG-SVA (3.4 kDa). Following
purification, the acrylate-decorated streptavidin was then mixed into the prepolymer and
covalently bound into the acrylate-PEG-acrylate hydrogel network during gelation by
acrylate polymerization (Fig. 3a). Cell-free PEG-SA microtissues containing conjugated
acrylate-PEG-streptavidin were stained to verify biotin-binding capacity using biotin-4-
fluorescein.We also confirmed the surface-availability of streptavidin with an anti-
streptavidin antibody , which was size restricted to only the surface of the microtissue (~7
nm mesh size34) . Both biotin fluorescence and antibody staining intensities increased with
the volumetric concentration of conjugated streptavidin (Fig. 3b).
With streptavidin incorporated into the hydrogel network, we were able to encode the
microtissues post-polymerization with 5′-biotin terminated oligonucleotides (Fig. 3c).
Streptavidin-biotin based DNA-functionalization of microtissues is simple, modular, and
cytocompatible. Post-polymerization encoding of microtissues with biotin-DNA avoids UV
damage that would occur by pre-mixing acrylated-DNA into the prepolymer,38-39 and
allows the same batch of microtissues to be labeled after culture in various conditions. Other
bioconjugation methods exist to modify hydrogel networks post-encapsulation, such as
maleimide or NHS chemistries40 but often require reaction conditions that are incompatible
with maintaining the viability of encapsulated cells. To ensure that DNA bound to
microtissues using the streptavidin-biotin interaction was available to hybridize with DNA
displayed on a surface, we incubated DNA-encoded microtissues with 1 μm polystyrene
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beads coated with the complementary oligonucleotide (Fig. 3c). After washing to remove
non-specifically bound material, microtissues encoded with the complementary sequence
were thoroughly coated with beads visible as bright, punctate spots (Fig. 3d). Conversely,
beads did not specifically hybridize to control microtissues (Fig. 3d). In order to maximize
bead-microtissue hybridization, we investigated conjugating acrylate-PEG-SVA to
streptavidin at several molar ratios (Fig. S1). As expected, microtissues incorporating
streptavidin with few acrylate pendants (10:1 molar ratio, mobility shift assay) did not
promote bead hybridization as effectively as streptavidin modified with a higher number of
acrylate groups (25:1 to 50:1 molar ratio), which was used for all further studies. Gels
incorporating over-decorated streptavidin (1000:1 molar ratio) were also not as efficient in
mediating bead-microtissue hybridization, suggesting that overmodification and/or steric
hindrance plays an important role in DNA-binding capacity.
Binding efficiency and specificity of DNA-templated assembly
Having shown that cell-free microtissues can be coated with DNA and hybridize specifically
to complementary beads, we next investigated the potential of microtissue assembly into
mesoscale patterns determined by an encoded template. To create such a template, we
spotted increasing concentrations of DNA (sequence A’) onto a functionalized glass slide
using conventional microarray technology. DNA-functionalized microtissues (A; containing
green marker beads) were allowed to settle onto microarray slides from suspension, at which
time non-hybridized microtissues were gently washed off the slide. The number of
microtissues bound to templating array spots increased with higher spotting concentrations
of templating ssDNA (Fig. 4a), plateauing at 250 μM, an order of magnitude higher than
typical epoxy-silane based microarray spotting concentrations. Spots were fully covered by
microtissues at this highest DNA density. To determine the capture efficiency, we seeded
microtissues at varying densities (microtissues per mm2, Fig. 4b). At contact-limited
(hexagonally close-packed) seeding concentrations, we achieved 100% capture efficiency,
indicating that if a microtissue settled onto a complementary spot, hybridization and binding
would occur.
Similar efficiencies have been observed during the DNA-templated assembly of materials
ranging in scale from molecules to nanoparticles to single cells23, 41-46. Until now, DNA-
templated assembly has not been extended to larger units such as microtissues (100 μm),
which present unique challenges in mass transport.47 At these mesoscopic scales, gravity
and friction become important factors in the ability of DNA-coated surfaces to sufficiently
interact. During washing steps, stronger viscous drag forces on the microtissues necessitate a
large number of hybridization bonds between the microtissues and templating surface to
overcome microtissue removal. Here, to compensate for microtissue size, we optimize
microtissue DNA functionalization and template spotting to achieve high DNA surface
densities, enabling the first demonstration of large structure DNA-templated assembly.
During our assembly process, minimal microtissue binding was observed between spots and
on non-complementary templating spots (Fig. 4b), which was largely made possible by our
control over microtissue shape. This low background binding allowed us to sequentially
pattern multiple microtissue types, each encoded with an orthogonal oligonucleotide
sequence, with over 90% specificity (Fig. 4c, d) and across large areas in under 15 minutes
(Fig. 4e, f). Furthermore, we were able to build 3D structures (Fig. 4g, h) by filling template
spots (B’) with a layer of microtissues (B), and then seeding a second layer of
complementary microtissues (B’) that bind on and around microtissues in the first layer.
Together, these experiments demonstrate the ease of achieving organizational control at
macroscopic length scales by microtissue assembly.
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DNA-templated assembly of multicellular tissue constructs
In order to apply DNA-templated patterning to the assembly of multicellular constructs, we
next focused on encapsulating cells into uniform and highly viable cell-laden microtissues.
To improve the consistency of cell encapsulation (Fig. S2), we increased the specific gravity
of our cell suspensions to prevent cell settling during injection. We chose a density gradient
medium (OptiPrep), based on an iodinated small molecule, that increases specific gravity
without affecting viscosity or cross-linked hydrogel network density, and easily diffuses out
of the polymerized microtissues. With these changes, we attained cell encapsulation
matching a Poisson distribution (Fig. 5b). In addition, we replaced the hydrocarbon oil phase
with an oxygen-permeable fluorocarbon oil (Fomblin) to allow immediate quenching of
excess free radicals post-UV exposure.48 Notably, using fluorocarbon oil, cells were able to
tolerate a wide range of total UV exposures (mJ/cm2) while maintaining >90% viability
(Fig. 5c). As a result of these changes, several adhesive and suspension cell lines, including
adherent mesenchymal (fibroblasts), nonadherent mesenchymal (lymphoblasts) and adherent
epithelial (adenocarcinoma), were uniformly encapsulated into microtissues with
consistently high viability (Fig. 5a). Variations in average viability between cell types (e.g.
J2-3T3 vs. TK6) could be due a number of cell type differences including susceptibility to
DNA damage.49 For cell lines sensitive to UV, photoinitiators in the visible-light range
could be substituted into our material system.50
These are many advantages associated with patterning cellular microtissues rather than
single cells.43-44 Firstly, cells can be encapsulated in a modular scaffold with customized
ECM molecules (e.g. RGDS) to promote certain phenotypes. As an example, we added
acrylated RGDS peptide to the prepolymer during fibroblast encapsulation. By Day 2 post-
encapsulation, fibroblasts began spreading within these adhesive microtissues (Fig. 5d, Fig.
S3). Secondly, microtissues containing one cell type can be first cultured separately to
stabilize homotypic interactions before they are self-assembled with other microtissues to
activate heterotypic interactions. For instance, when cultured for several days,
adenocarcinoma cells encapsulated from a single-cell suspension formed multicellular
spheroids (Fig. 5e). In addition, encoding DNA is bound to the hydrogel scaffold rather than
directly onto the cell membrane,43-44 where covalently bound ligands may be susceptible to
recycling or may potentially modify cell function. Encoded microtissues can remain in
assembled patterns for an extended period of time without additional measures for
immobilization (e.g. embedding in agarose23), and then removed for further culture,
isolation, and biochemical analysis.27 DNA provides a way for programmed detachment via
dehybridization (e.g. competitive binding with free ssDNA) or cleavage (e.g. restriction
enzymes).43 Alternatively, patterned microtissues could be stabilized into a contiguous
tissue by a secondary hydrogel polymerization29 or cell adhesion between microtissues to
form 3D sheets for implantation (Fig. S4).
Finally, to demonstrate DNA-templated 5 positioning of microtissues containing distinct cell
types into pre-defined patterns, we encapsulated adenocarcinoma cells (blue) and fibroblasts
(green) into separate microtissues and encoded them with orthogonal DNA sequences (C
and D respectively). These microtissues were then seeded onto an array printed with
hexagonal clusters of complementary DNA (C’ centered within 6 spots of D’), forming co-
cultures of the two cell types representative of a tumor nodule surrounded by stromal cells
(Fig. 5f). Multicellular constructs patterned using this method could be relevant model
systems for studying cancer-stroma interactions in 3D. Notably, although DNA-templated
microtissues are patterned on a 2D template, cells are encapsulated and respond to a locally
3D microenvironment, e.g. developing into tumor spheroids (Fig. 5e) rather than growing as
a 2D monolayer.16 Heterotypic signaling from stromal cells has been shown to contribute to
tumor invasion and metastasis.9 The combination of precise spatial control, similar to that
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achieved in 2D,10 but with a 3D environment, will be critical toward elucidating such cell
signaling mechanisms.
Conclusions
We have presented a method to organize multiple cell types within a 3D microenvironment
that integrates the top-down patterning of a DNA microarray template with the bottom-up
assembly of DNA-encoded, cell-laden microtissues. This is the first demonstration of
microtissue assembly that is directed by specific biomolecular interactions. The speed and
scalability of the assembly process is compatible with DNA templates that can be fabricated
by other top-down techniques, such as microfabrication and micro-contact printing, for a
diverse range of features and patterning resolution. The programmable molecular interaction
of DNA to direct assembly has the potential to be extended to even larger sets of encoding
sequences to create more complex heterogeneous structures. The ability to precisely control
cell-cell interactions (e.g. cancer-stromal cell, hepatic-nonparenchymal cell) via microfluidic
cell encapsulation and DNA-templated microtissue assembly provides a unique opportunity
to increase our fundamental understanding of complex diseases or to construct highly
functional tissue-engineered implants.
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Schematic of microtissue encapsulation, functionalization, and DNA-templated self
assembly. Cells are injected with a photopolymerizable hydrogel prepolymer into a high-
throughput microfluidic encapsulation device. Droplets of the cell-prepolymer mixture are
exposed to UV on-chip to form streptavidin-containing microtissues which are then coated
with 5′-biotin terminated oligonucleotides. Encoded microtissues containing different cell
types are seeded on a DNA microarray template which directs the binding of microtissues to
specific spots on the templating surface, attaining sequential DNA-templated patterning of
cell-laden microtissues.
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Microencapsulation device. (a) Overview of device showing two aqueous input streams (red,
blue) dispersed by shear flow from an oil stream into droplets that mix (purple) and travel
down the UV-exposure channel. (b) Prepolymer (2× concentrated) and a cell suspension
meet and flow into a 60 μm droplet generating nozzle. Vertical columns on either side of the
channel provide visual references (50-100 μm below, 100-150 μm above) for real-time
adjustment of droplet size. See Supporting Information for movie. (c) Droplets pass through
a bumpy serpentine mixer section to thoroughly disperse cells in prepolymer and are then
polymerized by UV irradiation from a curing lamp. (d) Microtissues collected from the
device (6000/min) are spherical and monodisperse. (e) Microtissue size is controlled by the
relative flow rates of the combined aqueous phase (QP) and the continuous oil phase (QO),
and increases with prepolymer:oil flow ratio. (f) Adding small amounts of Krytox 157 FSH
fluorosurfactant into the oil decreased droplet diameter at all flow ratios, allowing higher
prepolymer flow rates for a given microtissue size.
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Microtissue functionalization. (a) The primary hydrogel component, acrylate-PEG20k-
acrylate macromonomer, was mixed with conjugated acrylate-PEG-streptavidin (0-2 mg/ml)
before photo-initiated free radical polymerization, forming a hydrogel network that is
decorated with pendant streptavidin proteins. (b) PEG-streptavidin microtissues stained with
biotin-4-fluorescein, which can freely diffuse through the hydrogel network, and anti-
streptavidin IgG which is restricted to the surface of the microtissues. The intensity of
biotin-4-fluorescein staining increased linearly with the bulk concentration of covalently-
bound streptavidin, while antibody stains for surface concentration increased only as a
power of bulk concentration. (c) PEG-SA microtissues are further functionalized with
biotin-ssDNA. The availability of this ssDNA to hybridize with a templating surface was
tested using 1 μm fluorescent beads coated with DNA. (d) Microtissues with the appropriate
complementary sequence were coated with hybridized beads. No beads hybridized to
control-sequence microtissues, which remained dark in the green channel and showed only
encapsulated marker beads in the phase image.
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Capture efficiency and specificity of DNA-directed microtissue assembly. (a) Number of
DNA-functionalized microtissues containing fluorescent beads as markers captured on
microarray spots with increasing spotting concentration of complementary oligonucleotide.
(b) Quantified assembly results from microtissues seeded over an array of complementary
spots at low, medium (shown on the left), and high (close-packed) % surface coverage.
Control arrays of non-complementary spots remained blank. (c) Three-color (RGB)
microtissue assembly using a set of orthogonal oligonucleotide sequences: B (red), C
(green), and D (blue). Microtissues contain encapsulated marker beads. (d) Quantified
percentages of microtissues on target spots (1 column) vs. off-target spots (2 columns). (e)
MIT logo assembled in microtissues of C (green) and D (blue), and (f) photograph of
templating slide illustrating scale of assembled microtissue patterns. (g) Maximum intensity
projection and (h) volume reconstructions from multi-photon scans of 3D microtissue
structure formed by templating a first layer of microtissues (B, green) and then assembling a
second layer of complementary microtissues (B’, red).
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Cell encapsulation and microtissue culture. (a) Rat fibroblast (J2-3T3) and human
lymphoblast (TK6) cell lines uniformly encapsulated within microtissues and stained for
viability. (b) Histogram of J2-3T3 distribution within microtissues and comparison to
optimal Poisson statistics. (c) Viability of J2-3T3 and TK6 cells three hours post-
encapsulation at increasing % UV overexposure past the minimum intensity required to fully
polymerize microtissues. (d) J2-3T3 cells attached and spread within microtissues decorated
with RGDS peptides. (e) Human lung adenocarcinoma (A549) cells aggregated to form
multicellular tumor spheroids within microtissues. (f) Microtissues encapsulating either
J2-3T3 (CellTracker Green) or A549 cells (CellTracker Blue) were self-assembled into
composite hexagonal clusters.
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